-
1
-
-
0030763592
-
Glucocorticoid osteoporosis - Mechanisms and management
-
Reid IR (1997) Glucocorticoid osteoporosis - mechanisms and management. Eur J Endocrinol 137:209-217
-
(1997)
Eur J Endocrinol
, vol.137
, pp. 209-217
-
-
Reid, I.R.1
-
2
-
-
0025101215
-
Glucocorticoid-induced osteoporosis: Pathogenesis and management
-
Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364
-
(1990)
Ann Intern Med
, vol.112
, pp. 352-364
-
-
Lukert, B.P.1
Raisz, L.G.2
-
3
-
-
0032880837
-
Effect of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: Possible mechanisms of glucocorticoid-induced bone loss
-
Kim CH, Cheng SL, Kim GS (1999) Effect of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss. J Endocrinol 162:371-379
-
(1999)
J Endocrinol
, vol.162
, pp. 371-379
-
-
Kim, C.H.1
Cheng, S.L.2
Kim, G.S.3
-
4
-
-
0024554774
-
Bone histomorphometry in glucocorticoid-induced osteoporosis
-
Dempster D (1998) Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 13:137-141
-
(1998)
J Bone Miner Res
, vol.13
, pp. 137-141
-
-
Dempster, D.1
-
5
-
-
0033983726
-
Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one cycle etidronate therapy
-
Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H (2000) Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one cycle etidronate therapy. Calcif Tissue Int 66:195-199
-
(2000)
Calcif Tissue Int
, vol.66
, pp. 195-199
-
-
Fujita, T.1
Satomura, A.2
Hidaka, M.3
Ohsawa, I.4
Endo, M.5
Ohi, H.6
-
6
-
-
0032528180
-
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone
-
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282
-
(1998)
J Clin Invest
, vol.102
, pp. 274-282
-
-
Weinstein, R.S.1
Jilka, R.L.2
Parfitt, A.M.3
Manolagas, S.C.4
-
7
-
-
0030989969
-
Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
-
Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K (1997) Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 234:137-142
-
(1997)
Biochem Biophys Res Commun
, vol.234
, pp. 137-142
-
-
Tsuda, E.1
Goto, M.2
Mochizuki, S.3
Yano, K.4
Kobayashi, F.5
Morinaga, T.6
Higashio, K.7
-
8
-
-
0031005576
-
Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
-
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
-
(1997)
Cell
, vol.89
, pp. 309-319
-
-
Simonet, W.S.1
Lacey, D.L.2
Dunstan, C.R.3
Kelley, M.4
Chang, M.S.5
-
9
-
-
0032540319
-
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
-
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176
-
(1998)
Cell
, vol.93
, pp. 165-176
-
-
Lacey, D.L.1
Timms, E.2
Tan, H.L.3
Kelley, M.J.4
Dunstan, C.R.5
-
10
-
-
0035090305
-
Glucocorticoid decreases circulating osteoprotegerin (OPG): Possible mechanism for glucocorticoid induced osteoporosis
-
Sasaki N, Kusano E, Ando Y, Yano K, Tsuda E, Asano Y (2001) Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis. Nephrol Dial Transplant 16:479-482
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 479-482
-
-
Sasaki, N.1
Kusano, E.2
Ando, Y.3
Yano, K.4
Tsuda, E.5
Asano, Y.6
-
11
-
-
0036270216
-
Changes in osteoprotegerin (OPG) and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis
-
Sasaki N, Kusano E, Ando Y, Nemoto J, Iimura O, Ito C, Takeda S, Yano K, Tsuda E, Asano Y (2002) Changes in osteoprotegerin (OPG) and markers of bone metabolism during glucocorticoid treatment in patients with chronic glomerulonephritis. Bone 30: 853-858
-
(2002)
Bone
, vol.30
, pp. 853-858
-
-
Sasaki, N.1
Kusano, E.2
Ando, Y.3
Nemoto, J.4
Iimura, O.5
Ito, C.6
Takeda, S.7
Yano, K.8
Tsuda, E.9
Asano, Y.10
-
12
-
-
0033624881
-
Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis
-
Shiraki M, Shiraki Y, Aoki C, Miura M (2000) Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15: 515-521
-
(2000)
J Bone Miner Res
, vol.15
, pp. 515-521
-
-
Shiraki, M.1
Shiraki, Y.2
Aoki, C.3
Miura, M.4
-
13
-
-
0030614790
-
Vitamin K2 enhances osteocalcin accumulation in the extracelluar matrix of human osteoblasts in vitro
-
Koshihara Y, Hoshi K (1997) Vitamin K2 enhances osteocalcin accumulation in the extracelluar matrix of human osteoblasts in vitro. J Bone Miner Res 12:431-438
-
(1997)
J Bone Miner Res
, vol.12
, pp. 431-438
-
-
Koshihara, Y.1
Hoshi, K.2
-
14
-
-
0036860358
-
Vitamin K(2) (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats
-
Hara K, Kobayashi M, Akiyama Y (2002) Vitamin K(2) (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 31:575-581
-
(2002)
Bone
, vol.31
, pp. 575-581
-
-
Hara, K.1
Kobayashi, M.2
Akiyama, Y.3
-
15
-
-
0029805844
-
New developments in biochemical markers for osteoporosis
-
Garnero P, Delmas PD (1996) New developments in biochemical markers for osteoporosis. Calcif Tissue Int 59:S2-S9
-
(1996)
Calcif Tissue Int
, vol.59
-
-
Garnero, P.1
Delmas, P.D.2
-
16
-
-
0031976711
-
Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay
-
Halleen JM, Hentunen TA, Karp M, Kakonen SM, Pettersson K, Vaananen HK (1998) Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J Bone Miner Res 13:683-687
-
(1998)
J Bone Miner Res
, vol.13
, pp. 683-687
-
-
Halleen, J.M.1
Hentunen, T.A.2
Karp, M.3
Kakonen, S.M.4
Pettersson, K.5
Vaananen, H.K.6
-
17
-
-
0033026628
-
Immunological characterization of circulating osteoprotegerin/ osteoclastogenesis inhibitory factor: Increased serum concentration in postmenopausal women with osteoporosis
-
Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y (1999) Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentration in postmenopausal women with osteoporosis. J Bone Miner Res 14:518-527
-
(1999)
J Bone Miner Res
, vol.14
, pp. 518-527
-
-
Yano, K.1
Tsuda, E.2
Washida, N.3
Kobayashi, F.4
Goto, M.5
Harada, A.6
Ikeda, K.7
Higashio, K.8
Yamada, Y.9
-
18
-
-
0021279569
-
Effect of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans
-
Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984) Effect of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36:245-252
-
(1984)
Calcif Tissue Int
, vol.36
, pp. 245-252
-
-
Gennari, C.1
Imbimbo, B.2
Montagnani, M.3
Bernini, M.4
Nardi, P.5
Avioli, L.V.6
-
19
-
-
0033768877
-
Glucocorticoid-induced osteoporosis: Pathogenesis and management
-
Nishimura J, Ikuyama S (2000) Glucocorticoid-induced osteoporosis: pathogenesis and management. J Bone Miner Metab 18:350-352
-
(2000)
J Bone Miner Metab
, vol.18
, pp. 350-352
-
-
Nishimura, J.1
Ikuyama, S.2
-
20
-
-
0033979247
-
Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis
-
Yonemura K, Kimura M, Miyaji T, Hishida A (2000) Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int 66:123-128
-
(2000)
Calcif Tissue Int
, vol.66
, pp. 123-128
-
-
Yonemura, K.1
Kimura, M.2
Miyaji, T.3
Hishida, A.4
-
21
-
-
0032577903
-
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
-
Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki SI, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashi K, Ozawa H (1998) Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247:610-615
-
(1998)
Biochem Biophys Res Commun
, vol.247
, pp. 610-615
-
-
Mizuno, A.1
Amizuka, N.2
Irie, K.3
Murakami, A.4
Fujise, N.5
Kanno, T.6
Sato, Y.7
Nakagawa, N.8
Yasuda, H.9
Mochizuki, S.I.10
Gomibuchi, T.11
Yano, K.12
Shima, N.13
Washida, N.14
Tsuda, E.15
Morinaga, T.16
Higashi, K.17
Ozawa, H.18
-
22
-
-
0031721590
-
Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids
-
Vidal NOA, Brandstrom H, Jonsson KB, Ohlsson C (1998) Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids. J Endocrinol 159:191-195
-
(1998)
J Endocrinol
, vol.159
, pp. 191-195
-
-
Vidal, N.O.A.1
Brandstrom, H.2
Jonsson, K.B.3
Ohlsson, C.4
-
23
-
-
0033304809
-
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis
-
Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389
-
(1999)
Endocrinology
, vol.140
, pp. 4382-4389
-
-
Hofbauer, L.C.1
Gori, F.2
Riggs, B.L.3
Lacey, D.L.4
Dunstan, C.R.5
Spelsberg, T.C.6
Khosla, S.7
-
24
-
-
0345701383
-
Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture
-
Koshihara Y, Hoshi K, Okawara R, Ishibashi H, Yamamoto S (2003) Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J Endocrinol 176:339-348
-
(2003)
J Endocrinol
, vol.176
, pp. 339-348
-
-
Koshihara, Y.1
Hoshi, K.2
Okawara, R.3
Ishibashi, H.4
Yamamoto, S.5
-
25
-
-
0031664287
-
Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men
-
Gram J, Junker P, Nielsen HK, Bollerslev J (1998) Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men. Bone 23:297-302
-
(1998)
Bone
, vol.23
, pp. 297-302
-
-
Gram, J.1
Junker, P.2
Nielsen, H.K.3
Bollerslev, J.4
-
26
-
-
0025869548
-
The course of biochemical parameters of bone turnover during treatment with corticosteroids
-
Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocr Metab 72: 382-386
-
(1991)
J Clin Endocr Metab
, vol.72
, pp. 382-386
-
-
Prummel, M.F.1
Wiersinga, W.M.2
Lips, P.3
Sanders, G.T.B.4
Sauerwein, H.P.5
-
27
-
-
0035706128
-
Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro
-
Yamaguchi M, Ma ZJ (2001) Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro. Mol Cell Biochem 228:39-47
-
(2001)
Mol Cell Biochem
, vol.228
, pp. 39-47
-
-
Yamaguchi, M.1
Ma, Z.J.2
-
28
-
-
0036317417
-
Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures
-
Lee SK, Lorenzo JA (2002) Regulation of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures. Bone 31:252-259
-
(2002)
Bone
, vol.31
, pp. 252-259
-
-
Lee, S.K.1
Lorenzo, J.A.2
-
29
-
-
0029166250
-
The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain
-
Hara K, Akiyama Y, Nakamura T, Murota S, Morita I (1995) The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16:179-184
-
(1995)
Bone
, vol.16
, pp. 179-184
-
-
Hara, K.1
Akiyama, Y.2
Nakamura, T.3
Murota, S.4
Morita, I.5
-
30
-
-
0033678846
-
Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures
-
Takeuchi Y, Suzawa M, Fukumoto S, Fujita T (2000) Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 27:769-776
-
(2000)
Bone
, vol.27
, pp. 769-776
-
-
Takeuchi, Y.1
Suzawa, M.2
Fukumoto, S.3
Fujita, T.4
-
31
-
-
0031093928
-
Serum undercarboxylated osteocalcin and the risk of hip fracture
-
Seibel MJ, Robins SP, Bilezikian JP (1997) Serum undercarboxylated osteocalcin and the risk of hip fracture. J Clin Endocr Metab 82:717-718
-
(1997)
J Clin Endocr Metab
, vol.82
, pp. 717-718
-
-
Seibel, M.J.1
Robins, S.P.2
Bilezikian, J.P.3
-
32
-
-
0035127621
-
Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures
-
Takahashi M, Naitou K, Ohishi T, Kushiba K, Miura M (2001) Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol 54:219-224
-
(2001)
Clin Endocrinol
, vol.54
, pp. 219-224
-
-
Takahashi, M.1
Naitou, K.2
Ohishi, T.3
Kushiba, K.4
Miura, M.5
-
33
-
-
0027484982
-
Circulating levels of vitamin K1 and K2 decreased in elderly women with hip fracture
-
Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD (1993) Circulating levels of vitamin K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 8:1241-1245
-
(1993)
J Bone Miner Res
, vol.8
, pp. 1241-1245
-
-
Hodges, S.J.1
Akesson, K.2
Vergnaud, P.3
Obrant, K.4
Delmas, P.D.5
-
34
-
-
0034980829
-
Carboxylation of osteocalcin may be related to bone quality: A possible mechanism of bone fracture prevention by vitamin K
-
Sugiyama T, Kawai S (2001) Carboxylation of osteocalcin may be related to bone quality: a possible mechanism of bone fracture prevention by vitamin K. J Bone Miner Metab 19:146-149
-
(2001)
J Bone Miner Metab
, vol.19
, pp. 146-149
-
-
Sugiyama, T.1
Kawai, S.2
-
35
-
-
0035079560
-
Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol
-
Inoue T, Sugiyama T, Matsubara T, Kawai S, Furukawa S (2001) Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol. Endocr J 48:11-18
-
(2001)
Endocr J
, vol.48
, pp. 11-18
-
-
Inoue, T.1
Sugiyama, T.2
Matsubara, T.3
Kawai, S.4
Furukawa, S.5
-
36
-
-
0036043865
-
Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: Effects of concomitant administration of vitamin K2
-
Hidaka T, Hasegawa T, Fujimura M, Sakai M, Saito S (2002) Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K2. J Bone Miner Metab 20:235-239
-
(2002)
J Bone Miner Metab
, vol.20
, pp. 235-239
-
-
Hidaka, T.1
Hasegawa, T.2
Fujimura, M.3
Sakai, M.4
Saito, S.5
|